KR100572426B1 - 단백질 제조방법 - Google Patents
단백질 제조방법 Download PDFInfo
- Publication number
- KR100572426B1 KR100572426B1 KR1019980041127A KR19980041127A KR100572426B1 KR 100572426 B1 KR100572426 B1 KR 100572426B1 KR 1019980041127 A KR1019980041127 A KR 1019980041127A KR 19980041127 A KR19980041127 A KR 19980041127A KR 100572426 B1 KR100572426 B1 KR 100572426B1
- Authority
- KR
- South Korea
- Prior art keywords
- carbon source
- sugar
- glucose
- feed
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 15
- 230000014616 translation Effects 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 20
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 14
- 210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 6
- 238000012258 culturing Methods 0.000 claims abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 30
- 239000008103 glucose Substances 0.000 claims description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 26
- 108010011619 6-Phytase Proteins 0.000 claims description 18
- 229940085127 phytase Drugs 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 10
- 229940088598 enzyme Drugs 0.000 claims description 10
- 235000000346 sugar Nutrition 0.000 claims description 10
- 108010025188 Alcohol oxidase Proteins 0.000 claims description 9
- 241000320412 Ogataea angusta Species 0.000 claims description 9
- 108090000698 Formate Dehydrogenases Proteins 0.000 claims description 7
- 230000014509 gene expression Effects 0.000 claims description 7
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 108010059892 Cellulase Proteins 0.000 claims description 4
- 241000235058 Komagataella pastoris Species 0.000 claims description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- 230000003252 repetitive effect Effects 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 241000235648 Pichia Species 0.000 claims description 3
- 239000003262 industrial enzyme Substances 0.000 claims description 3
- -1 naraginase Proteins 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- LJCNDNBULVLKSG-UHFFFAOYSA-N 2-aminoacetic acid;butane Chemical compound CCCC.CCCC.NCC(O)=O LJCNDNBULVLKSG-UHFFFAOYSA-N 0.000 claims description 2
- 239000004382 Amylase Substances 0.000 claims description 2
- 102000013142 Amylases Human genes 0.000 claims description 2
- 108010065511 Amylases Proteins 0.000 claims description 2
- 102000016938 Catalase Human genes 0.000 claims description 2
- 108010053835 Catalase Proteins 0.000 claims description 2
- 102000029816 Collagenase Human genes 0.000 claims description 2
- 108060005980 Collagenase Proteins 0.000 claims description 2
- 101710093617 Dihydroxyacetone synthase Proteins 0.000 claims description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 2
- 108010067193 Formaldehyde transketolase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 239000004367 Lipase Substances 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 101100456571 Mus musculus Med12 gene Proteins 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- 108010059820 Polygalacturonase Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 235000019418 amylase Nutrition 0.000 claims description 2
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229940105657 catalase Drugs 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 229960002424 collagenase Drugs 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- 150000002016 disaccharides Chemical class 0.000 claims description 2
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 2
- 235000021433 fructose syrup Nutrition 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 239000001573 invertase Substances 0.000 claims description 2
- 235000011073 invertase Nutrition 0.000 claims description 2
- 235000019421 lipase Nutrition 0.000 claims description 2
- 229940040461 lipase Drugs 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 235000013379 molasses Nutrition 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- PVFDPMYXCZLHKY-MLLWLMKGSA-M sodium [(1R,2R,4aR,8aS)-2-hydroxy-5-[(2E)-2-[(4S)-4-hydroxy-2-oxooxolan-3-ylidene]ethyl]-1,4a,6-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl sulfate Chemical compound [Na+].C([C@@H]1[C@](C)(COS([O-])(=O)=O)[C@H](O)CC[C@]11C)CC(C)=C1C\C=C1/[C@H](O)COC1=O PVFDPMYXCZLHKY-MLLWLMKGSA-M 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 3
- 101100226950 Pichia angusta FMDH gene Proteins 0.000 claims 1
- 108090000637 alpha-Amylases Proteins 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000037353 metabolic pathway Effects 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 235000019419 proteases Nutrition 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 84
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 241001149671 Hanseniaspora uvarum Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000012527 feed solution Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 229910019931 (NH4)2Fe(SO4)2 Inorganic materials 0.000 description 4
- 238000009010 Bradford assay Methods 0.000 description 4
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 4
- 241000080590 Niso Species 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- 235000019157 thiamine Nutrition 0.000 description 4
- 239000011721 thiamine Substances 0.000 description 4
- 241001225321 Aspergillus fumigatus Species 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 102000012607 Thrombomodulin Human genes 0.000 description 2
- 108010079274 Thrombomodulin Proteins 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 210000000352 storage cell Anatomy 0.000 description 2
- 241001149669 Hanseniaspora Species 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97117021.2 | 1997-10-01 | ||
| EP97117021 | 1997-10-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR19990036734A KR19990036734A (ko) | 1999-05-25 |
| KR100572426B1 true KR100572426B1 (ko) | 2006-06-21 |
Family
ID=8227420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019980041127A Expired - Lifetime KR100572426B1 (ko) | 1997-10-01 | 1998-09-30 | 단백질 제조방법 |
Country Status (12)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451572B1 (en) * | 1998-06-25 | 2002-09-17 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
| WO2000058481A2 (en) | 1999-03-31 | 2000-10-05 | Cornell Research Foundation, Inc. | Phosphatases with improved phytase activity |
| US6841370B1 (en) | 1999-11-18 | 2005-01-11 | Cornell Research Foundation, Inc. | Site-directed mutagenesis of Escherichia coli phytase |
| CA2465202C (en) | 2001-10-31 | 2014-01-21 | Phytex, Llc | Phytase-containing animal food and method |
| KR100429331B1 (ko) * | 2002-01-29 | 2004-04-29 | 재단법인 목암생명공학연구소 | 재조합 효모를 이용한 에스에이치엘케이엔-1 단백질의대량생산방법 |
| ES2285188T3 (es) * | 2002-07-15 | 2007-11-16 | Immunex Corporation | Metodo y medios para controlar sialilacion de proteinas producidas por celulas de mamifero. |
| ATE492631T1 (de) | 2002-09-13 | 2011-01-15 | Cornell Res Foundation Inc | Verwendung von mutationen zur verbesserung von aspergillus-phytasen |
| EP1660661A2 (en) | 2003-08-08 | 2006-05-31 | Arriva Pharmaceuticals, Inc. | Methods of protein production in yeast |
| DK1684719T3 (da) * | 2003-11-14 | 2012-01-30 | Baxter Int | Alfa-1-antitrypsin-sammensætninger og behandlingsfremgangsmåder, der anvender sådanne sammensætninger |
| WO2006036678A2 (en) * | 2004-09-22 | 2006-04-06 | Bioworks, Inc. | Transgenic strains of trichoderma and their use in biocontrol |
| US20070105768A1 (en) * | 2004-11-10 | 2007-05-10 | Rajiv Nayar | Dry recombinant human alpha 1-antitrypsin formulation |
| JP2008533981A (ja) * | 2005-03-24 | 2008-08-28 | ディーエスエム アイピー アセッツ ビー．ブイ． | 有益な化合物の微生物産生方法 |
| US7919297B2 (en) * | 2006-02-21 | 2011-04-05 | Cornell Research Foundation, Inc. | Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase |
| WO2007127912A2 (en) * | 2006-04-28 | 2007-11-08 | C5-6 Technologies, Inc. | Thermostable cellulase and methods of use |
| WO2008017066A2 (en) * | 2006-08-03 | 2008-02-07 | Cornell Research Foundation, Inc. | Phytases with improved thermal stability |
| DK2106447T3 (da) | 2007-01-26 | 2013-06-24 | Novozymes As | Fremgangsmåde til methanoluafhængig induktion fra methanolinducerbare promotorer i Pichia |
| US8192734B2 (en) | 2007-07-09 | 2012-06-05 | Cornell University | Compositions and methods for bone strengthening |
| HUE050997T2 (hu) * | 2008-05-06 | 2021-03-01 | Archer Daniels Midland Co | Keményítõ- és xilánbontó enzimek expresszálásával keményítõ és xilán alkoholos fermentációjára képes hõtûrõ Hansenula polymorpha élesztõtörzsek kifejlesztése |
| GB201308828D0 (en) * | 2013-03-12 | 2013-07-03 | Verenium Corp | Phytase |
| GB201308843D0 (en) | 2013-03-14 | 2013-07-03 | Verenium Corp | Phytase formulation |
| CN103159531A (zh) * | 2013-04-17 | 2013-06-19 | 广西新方向化学工业有限公司 | 一种含多种植物醇和中微量元素螯合的液体肥料及其制备方法 |
| KR20160033711A (ko) | 2013-07-25 | 2016-03-28 | 바스프 엔자임스 엘엘씨 | 피타아제 |
| CN107205432A (zh) | 2014-11-11 | 2017-09-26 | 克莱拉食品公司 | 用于生成卵清蛋白的方法和组合物 |
| CN104928271A (zh) * | 2015-07-06 | 2015-09-23 | 唐亚军 | 一种木聚糖酶的制备方法 |
| CN105200101B (zh) * | 2015-10-19 | 2019-04-16 | 华中农业大学 | 一种毕赤酵母菌体重复发酵表达外源蛋白的方法 |
| BR112022000545A2 (pt) | 2019-07-11 | 2022-04-05 | Clara Foods Co | Composições de proteína e produtos de consumo destas |
| US12096784B2 (en) | 2019-07-11 | 2024-09-24 | Clara Foods Co. | Protein compositions and consumable products thereof |
| US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
| WO2025077804A1 (en) * | 2023-10-12 | 2025-04-17 | Chengdu Kanghua Biological Products Co., Ltd. | Methanol monitoring method for the fermentation process of methanotrophic yeast |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0244920A1 (en) * | 1986-06-05 | 1987-11-11 | Unilever N.V. | Process for preparing a catalase-free oxidase and a catalase-free oxidase-containing yeast, and use thereof |
| WO1990003431A1 (en) * | 1988-09-26 | 1990-04-05 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Mixed feed recombinant yeast fermentation |
| EP0533492A2 (en) * | 1991-09-18 | 1993-03-24 | Amgen Inc. | A hepatitis B vaccine formulation incorporating a bile acid salt |
| KR970700775A (ko) * | 1994-10-25 | 1997-02-12 | 가와노 다케히코 | 단백질 제조방법(Method for Producing Protein) |
| KR0161148B1 (ko) * | 1995-10-11 | 1998-11-16 | 김은영 | 재조합 메탄올 자화 효모를 사용한 이종 단백질의 생산방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0423890A3 (en) | 1984-07-27 | 1991-07-03 | Unilever Nv | Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology |
| US4855231A (en) | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
| EP0242007B1 (en) * | 1986-11-24 | 1990-11-07 | Unilever N.V. | Process for preparing a catalase-free oxidase and a catalase-free oxidase-containing yeast, and use thereof |
| ES2056799T3 (es) * | 1987-07-17 | 1994-10-16 | Rhein Biotech Ges Fur Biotechn | Moleculas de adn codante para las regiones de control fmdh y gen estructural para una proteina que tiene una actividad de fmdh y su uso. |
| US5667986A (en) * | 1989-10-18 | 1997-09-16 | Delta Biotechnology Limited | Yeast promoter for expressing heterologous polypeptides |
| DK0684313T3 (da) | 1994-04-25 | 2006-11-06 | Dsm Ip Assets Bv | Polypeptider med phytaseaktivitet |
| CA2231948C (en) | 1997-03-25 | 2010-05-18 | F. Hoffmann-La Roche Ag | Modified phytases |
-
1998
- 1998-09-25 ES ES98118241T patent/ES2264181T3/es not_active Expired - Lifetime
- 1998-09-25 EP EP06001709A patent/EP1659173A1/en not_active Withdrawn
- 1998-09-25 DK DK98118241T patent/DK0911416T3/da active
- 1998-09-25 EP EP98118241A patent/EP0911416B1/en not_active Expired - Lifetime
- 1998-09-25 DE DE69834533T patent/DE69834533T2/de not_active Expired - Lifetime
- 1998-09-29 US US09/163,052 patent/US6204012B1/en not_active Expired - Lifetime
- 1998-09-29 JP JP27410498A patent/JP4162774B2/ja not_active Expired - Lifetime
- 1998-09-29 CA CA002249061A patent/CA2249061C/en not_active Expired - Lifetime
- 1998-09-29 IN IN2187MA1998 patent/IN188151B/en unknown
- 1998-09-30 AU AU87157/98A patent/AU748187B2/en not_active Expired
- 1998-09-30 BR BRPI9803807-9A patent/BR9803807B1/pt not_active IP Right Cessation
- 1998-09-30 KR KR1019980041127A patent/KR100572426B1/ko not_active Expired - Lifetime
- 1998-09-30 CN CNB98118992XA patent/CN1215175C/zh not_active Expired - Lifetime
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0244920A1 (en) * | 1986-06-05 | 1987-11-11 | Unilever N.V. | Process for preparing a catalase-free oxidase and a catalase-free oxidase-containing yeast, and use thereof |
| WO1990003431A1 (en) * | 1988-09-26 | 1990-04-05 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Mixed feed recombinant yeast fermentation |
| EP0533492A2 (en) * | 1991-09-18 | 1993-03-24 | Amgen Inc. | A hepatitis B vaccine formulation incorporating a bile acid salt |
| KR970700775A (ko) * | 1994-10-25 | 1997-02-12 | 가와노 다케히코 | 단백질 제조방법(Method for Producing Protein) |
| KR100405944B1 (ko) * | 1994-10-25 | 2004-03-22 | 미쯔비시 웰 파마 가부시키가이샤 | 단백질 제조방법 |
| KR0161148B1 (ko) * | 1995-10-11 | 1998-11-16 | 김은영 | 재조합 메탄올 자화 효모를 사용한 이종 단백질의 생산방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU748187B2 (en) | 2002-05-30 |
| EP1659173A1 (en) | 2006-05-24 |
| CN1218112A (zh) | 1999-06-02 |
| CA2249061A1 (en) | 1999-04-01 |
| EP0911416B1 (en) | 2006-05-17 |
| IN188151B (enrdf_load_html_response) | 2002-08-24 |
| BR9803807A (pt) | 2000-03-28 |
| JPH11169173A (ja) | 1999-06-29 |
| CA2249061C (en) | 2009-02-24 |
| JP4162774B2 (ja) | 2008-10-08 |
| EP0911416A3 (en) | 2000-01-19 |
| DE69834533D1 (de) | 2006-06-22 |
| EP0911416A2 (en) | 1999-04-28 |
| DK0911416T3 (da) | 2006-08-14 |
| AU8715798A (en) | 1999-04-22 |
| KR19990036734A (ko) | 1999-05-25 |
| DE69834533T2 (de) | 2006-10-12 |
| ES2264181T3 (es) | 2006-12-16 |
| CN1215175C (zh) | 2005-08-17 |
| BR9803807B1 (pt) | 2010-11-03 |
| US6204012B1 (en) | 2001-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100572426B1 (ko) | 단백질 제조방법 | |
| Mayer et al. | An expression system matures: a highly efficient and cost‐effective process for phytase production by recombinant strains of Hansenula polymorpha | |
| Tishkov et al. | Pilot scale production and isolation of recombinant NAD+‐and NADP+‐specific formate dehydrogenases | |
| Nidetzky et al. | Continuous enzymatic production of xylitol with simultaneous coenzyme regeneration in a charged membrane reactor | |
| JPH11169173A5 (enrdf_load_html_response) | ||
| JP3403412B2 (ja) | 単一微生物による発酵性炭素源の１，３−プロパンジオールへの生物転化 | |
| Ostergaard et al. | Physiological studies in aerobic batch cultivations of Saccharomyces cerevisiae strains harboring the MEL1 gene | |
| CN109207373B (zh) | 一株高产柠檬酸的微生物菌株及其发酵淀粉糖质生产柠檬酸的方法 | |
| AU2016361425B2 (en) | Genetically modified yeasts and fermentation processes using genetically modified yeasts | |
| CN108291189A (zh) | 在具有降低的clr2活性的丝状真菌中生产蛋白质的方法 | |
| US6268189B1 (en) | Fungal lactate dehydrogenase gene and constructs for the expression thereof | |
| KR20100081096A (ko) | 신규한 재조합 효모 균주 및 이를 이용한 에탄올 및 목적단백질의 동시 생산 방법 | |
| CN107922914A (zh) | 繁殖微生物及相关方法和系统 | |
| CN116157530A (zh) | 使用温度变化的芽孢杆菌工业发酵工艺 | |
| JP2004515249A (ja) | 菌類による異種たんぱく質の生産方法 | |
| EP2062967A1 (en) | Genetically engineered aspergillus | |
| CN108291191A (zh) | 在具有降低的clr1活性的丝状真菌中生产蛋白质的方法 | |
| Nidetzky et al. | Improved operational stability of cell‐free glucose‐fructose oxidoreductase from Zymomonas mobilis for the efficient synthesis of sorbitol and gluconic acid in a continuous ultrafiltration membrane reactor | |
| US5686277A (en) | Fermentation process for preparing xylitol using mutant cells | |
| WO2024003943A1 (en) | A novel proteins/peptides production platform in yeast | |
| CN117586999A (zh) | 一种半连续发酵高产酶新工艺 | |
| EP1016712B1 (en) | Process for producing S-Hydroxynitrile lyase | |
| US5196317A (en) | Overexpression of proteins in recombinant host cells | |
| Cha et al. | Enhancement of production of cloned glucoamylase under conditions of low aeration from recombinant yeast using a SUC2 promoter | |
| KR102613937B1 (ko) | 갈락토스 이용에 관여하는 모든 유전자가 결손된 효모 균주 및 이를 이용한 재조합 단백질 생산방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19980930 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20030926 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19980930 Comment text: Patent Application |
|
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 20041019 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20050531 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20060131 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20060412 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20060411 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20090408 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20100401 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20110328 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20120322 Start annual number: 7 End annual number: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20130320 Year of fee payment: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20130320 Start annual number: 8 End annual number: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20140320 Year of fee payment: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20140320 Start annual number: 9 End annual number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20160318 Year of fee payment: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160318 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20170317 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20170317 Start annual number: 12 End annual number: 12 |
|
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |
Termination date: 20190331 Termination category: Expiration of duration |